Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

Aortic valve stenosis” is an often-overlooked condition and a growing health concern in ageing societies such as Thailand.

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

CHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...

Bullock Creek baseball coach Mike Vayre is back in the dugout after undergoing quintuple-bypass surgery and an aortic valve ...